Table 1.
Study period | |||||||
Timepoint | Enrolment | Allocation | Intervention | 12-month follow-up | |||
April 2019 |
May 2019 |
June 2019 |
July 2019 |
August 2019 | September 2019 | June/August 2020 |
|
Enrolment | |||||||
Eligibility form | X | ||||||
Informed consent | X | ||||||
Allocation | X | ||||||
Interventions | |||||||
ME+TAU C1(1) | |||||||
ME+TAU C1(2) | |||||||
ME+TAU C2(1) | |||||||
ME+TAU C2(2) | |||||||
TAU alone C3 | |||||||
TAU alone C4 | |||||||
Assessments | |||||||
Sociodemographic | X | ||||||
DEBQ | X | X | X | X | X | ||
BITE | X | X | X | X | X | ||
EAT-26 | X | X | X | X | X | ||
FFMQ | X | X | X | X | X | ||
SCS | X | X | X | X | X | ||
MES | X | X | X | X | X | ||
GAD-7 | X | X | X | ||||
PHQ-9 | X | X | X | ||||
Weight (kg) | X | X | X | ||||
Waist perimeter (cm) | X | X | X | ||||
Vital signs (DBP, SBP) | X | X | X | ||||
Cholesterol (HDL, LDL) | X | X | X | ||||
Glucose | X | X | X | ||||
HbA1c | X | X | X | ||||
ALT | X | X | X |
ALT, alanine aminotransferase; BITE, Bulimic Investigatory Test Edinburgh; C, cluster (subgroup in brackets); DBP, diastolic blood pressure; DEBQ, Dutch Food Behaviour Questionnaire; EAT-26, Eating Attitude Test; FFMQ, Five Facet Mindfulness Questionnaire;GAD-7, General Anxiety Disorder; HbA1c, glycosylated haemoglobin;HDL, high density lipoprotein; LDL, low density lipoprotein; MES, Mindful Eating Scale; ME+TAU, Mindful eating;PHQ-9, Patient Health Questionnaire; SBP, systolic blood pressure; SCS, Self-Compassion Scale; TAU, treatment as usual.